Heart Tronics, Inc. (HRTT) Research
Heart Tronics, Inc., established in 1987 and headquartered in Studio City, California, is a medical technology company specializing in the research, development, and marketing of medical devices across the United States. These devices are designed to track and quantify biological signals, aiding in the identification of illnesses that affect an individual's well-being. Among its current offerings is the Fidelity 100 Monitor System, an integrated solution where its Model 100 Patient Module gathers, processes, and enhances electrocardiogram (ECG) data from a patient via ten electrodes, transmitting this information wirelessly to a laptop computer. Currently in development are several innovative products. The Fidelity 350 Holter Monitor is a portable device crafted to collect continuous ECG data for conditions like arrhythmia and fleeting heart diseases, allowing patients to maintain their normal routines outside of clinical settings. Another developmental product is the Fidelity 200 Event Recording System/Heart Tempo Card, an over-the-counter heart monitoring device intended for proactive detection by individuals who wish to keep an eye on their cardiac health. The company also produces the Cardiac Vest, a snug-fitting, flexible vest or undergarment where electrodes are integrated directly into the fabric. Additionally, the Fidelity 400 Intracardiac Monitor utilizes Heart Tronics' unique signal acquisition and amplification technology to interpret intracardiac signals obtained from a catheter inserted within the heart. The company, formerly known as Signalife, Inc., rebranded as Heart Tronics, Inc. in November 2008.
Market snapshot
- Symbol
- HRTT
- Price
- $0.00
- Day change
- 0.00%
- Market cap
- $56.0
- P/E ratio
- -0.00x
- 52-week range
- 0.000001-0.0007
- Sector
- Healthcare
- Industry
- Medical - Devices
Peer companies
Open Heart Tronics, Inc. (HRTT) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.